Provided that the present momentum is maintained, tuberculosis should be virtually eradicated from most of the developed countries within 50 years. Nevertheless, apathy on the part of doctors or administrators might appreciably delay this; moreover, some recent publications have shown some of the problems which will occur during the decline of the disease.
The death rate from tuberculosis has fallen from about 25 to about one per 100 000 in the past 30 years. This welcome decline, however, is less satisfactory than it seems.1 2 A survey of all new notifications in England and Wales of tuberculosis at any site from 1 October 1978 to 31 March 1979 was conducted by the Medical Research Council Tuberculosis and Chest Diseases Unit.3 Two years after the last patient had been notified an audit was undertaken of the chemotherapy prescribed for adults with pulmonary tuberculosis in the survey.' Of 1312 patients of white or Indian subcontinent ethnic origin (mostly the former), 163 (120 ) died before they had completed chemotherapy, a comparable proportion (90 ') occurring in Scotland.4 Roughly half of the patients died of tuberculosis and in a further third tuberculosis was a contributory factor. Most of these deaths occurred early, 3800 before the end of the first week of chemotherapy and 6900 by the end of four weeks. In the series described by Ellis and Webb 36 of the 60 deaths occurred during treatment, mostly within two months.2 In 10 patients tuberculosis was overwhelming, in six the cause of death was unconnected, and in four there was evidence of drug induced disease; 16 patients died suddenly and unexpectedly, the cause of death being obscure. Factors associated included a delay (mean five months) in starting treatment (22 patients The frequency of unexplained sudden death merits further study, including the role of depressed cellular immunity7 and of steroids.8 The latter are often prescribed in addition to chemotherapy in patients who are severely ill, and in the series described by Ellis and Webb patients in the sudden death group had been prescribed steroids less often than had those who deteriorated slowly.2 Moreover, as rifampicin is an inducer of hepatic drug metabolising enzymes, when it is used in combination with prednisolone the steroid is exerting considerably less effect than might be expected.9 Hence the conventional dose of 20 mg prednisolone daily may be insufficient and the dose should at least be doubled. It is also important to study whether cortisone acetate is to be preferred to prednisolone.10
The change in the age structure of patients with tuberculosis also creates a problem, because increasingly it is a disease of the elderly, particularly men. It may be more difficult to diagnose in the elderly: not only are there few causes of cough and sputum in young adults and many in middle aged and elderly men but the disease may present non-specifically as fever, loss of weight, and haematological disorders, the tuberculin test frequently giving a negative result. Compliance is also harder to achieve in the elderly because of factors such as apathy, poor eyesight, and poor memory, and side effects may be more troublesome.
Inevitably there is loss of skills in the management of a disease that is becoming rare-in the six month period of the survey there were no notifications at all from 32 local authority areas. Medical students in technically advanced countries may qualify without ever seeing a patient with tuberculosis, and many of their teachers may be relatively ignorant of the disease and its optimal treatment. As McNicol points out, with so VOLUME 288 NO 6426 PAGE 1249 few patients diagnostic thresholds alter and management skills atrophy, for many chest physicians must themselves be beginning to lack experience."
On the face of it, the chemotherapy of tuberculosis seems to be comparatively simple, but it is a question not only of individual drugs and their doses but also of combinations of drugs and duration. The policy of BCG vaccination of children aged 10-14 continues to be highly effective in preventing tuberculosis.22 Nevertheless, whereas in England and Wales in 1950-2 only 67 vaccinations were required to prevent one notification, the estimated figure for 1978 was 2300. A recent inquiry by the Central Public Health Laboratory showed that of 201 districts contacted in England and Wales, five had stopped routine vaccination of schoolchildren and 10 have their policy under review.22' The policy for BCG vaccination of schoolchildren will require to be kept under review but because of the mobility of the population it would seem unwise to abandon it until the risk of infection is low everywhere in Britain. Recent immunological studies suggest that it may be possible to design a vaccine which reliably primes various T cell subsets that will kill mycobacteria. 23 Chemoprophylaxis has never been used extensively in Europe, and the indications for its application in contacts have recently been detailed in an excellent code of practice.2' As the incidence of the disease steadily declines the sources of infection will be found more and more among the middle aged and elderly who were heavily infected in their youth when tuberculosis was widespread. Almost 30 years ago Mitchison first raised the question whether there might be a place for chemoprophylaxis of all tuberculin positive people when the disease had receded to such an extent that it had virtually ceased to be a problem.24 Isoniazid has been used in chemoprophylaxis because of its effectiveness, low toxicity, and low cost. It is more likely to cause hepatotoxicity in people aged over 35, however, and theoretically rifampicin is more likely to be effective, as it is more potent in destroying mycobacteria undergoing spurts of metabolism which cause the emergence of active disease. The use of rifampicin together with isoniazid in chemoprophylaxis is being evaluated, but it is important to know whether rifampicin alone is effective if chemoprophylaxis in the elderly is to be contemplated, given that some elderly patients handle rifampicin poorly and that the standard dose may need to be lowered.
As tuberculosis steadily declines and the skills in its diagnosis and management atrophy, a case could be made for establishing tuberculosis reference centres where these skills would be maintained and which would advise on all aspects of the disease, not least control measures. This might well enhance the rate of eradication of the disease. Another contributory factor in accelerating the rate of eradication is regular national surveillance of the problem, either yearly in smaller self contained communities such as Scotland4 or intermittently as in England and Wales,3 as this brings an element of quality control to both diagnosis and treatment.
The late Professor Etienne Bernard, of Paris, said that the first country to eliminate tuberculosis will be that country which regards it as a serious problem right to the end. We would do well to heed his advice. N W HORNE No one doubts that medical research will, sooner or,later, develop totally new ways to control some of the major tropical diseases but, as their populations increase, the developing countries cannot wait for technological miracles. In many areas more than half of the children die before the age of 5 from a lethal combination of malnutrition and infectious diseases susceptible to simple interventions well within the capacity of the most basic health care services.2 Until infant and child mortality falls, parents are unlikely to be interested in spacing or limiting their families.
In the long term, better health will depend on socioeconomic progress, environmental improvement, and the spread of education. Meanwhile, basic medical care is the immediate need and can also serve as a useful entry point for preventive health care programmes in the community. Even if it were considered desirable (and many of us now question this), there is no way in which the Western pattern of high cost technology, hospital based medical care, supplied by highly trained professionals, could be extended to cover the scattered villages and the crowded urban slum communities where many Third World families live. Their medical care must come through a network of local health workers, who should receive a short, practical training and be given the appropriate equipment for their work. These workers need support in the form of adequate back up facilities at outlying health centres and small district hospitals. This crucial interface is where the genuine appropriateness of many health related technologies will be put to the test.
To be considered appropriate, a technology should meet six criteria. Firstly, it must be effective-that is, it must work and fulfil its purpose in the circumstances in which it needs to be used. Secondly, it must be culturally acceptable and so fit into the hands, minds, and lives of its users without disrupting a social fabric that may already be fragile. (Nevertheless, if new ideas and techniques are introduced they may stimulate local enterprise and promote self sufficiency.) Thirdly, it must be affordable-though this does not imply that an appropriate technology must always be cheap. The trade offs between cost and effectiveness may be worth while, and the choice must be an informed one, made only after full consideration of all the resources that can be made available and the urgency and importance of the need to be met. Fourthly, it must be sustainable locally-that is, the technology should not be overdependent on imported skill for its continuing function, maintenance, and repair. Fifthly, it must be measurable; the impact and performance of any technology needs proper evaluation if it is to be recommended.: Finally, it must be politically responsible, for it is unwise to alter an existing balance in a way that might be counterproductive. For example, it might be unwise to encourage minimally trained health workers to take too great an initiative without first making sure that the powerful medical leaders in the area favour this delegation of responsibility and will help the health workers if they run into difficulties.
Techniques and equipment appropriate to the conditions in developing countries must never be stigmatised as second rate just because they may have been superseded in the West. To recall Voltaire, "the best is the enemy of the good."4 On the other hand, there should be no romanticism about the innate appropriateness of simple technologies. There are already several instances where advanced technologies have provided economical and effective "fixes"-for example, the vaccine safety marker (PATH (Program for Appropriate Technology in Health), Canal Place, 130 Nickerson Street, Seattle,
